Web-based Intervention for Long-term Breast Cancer Survivors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. Some of these LS-BC return to daily life without any problems; however, in many cases, they experience and have to deal with physical sequelae (chronic fatigue, pain, etc.) psychological sequelae (anxiety, depression, fear of recurrence, etc.) and social sequelae (altered interpersonal relationships, difficulty in returning to work, etc.). For many LS-BC, these health problems are not being met by health professionals. Thus there is a need to promote greater continuity and coordination between specialized oncology care and primary health care in order to enhance specific follow-up of these women in the community. However, the role of the primary health care team in the provision of care in the long-term cancer survival is not clearly defined and few actions have been aimed at improving care activities, standardizing procedures and protocols, developing documentation and registries and updating the training of health care professionals. Therefore, this study aim to design, implement, and evaluate a web based tailored intervention, using artificial intelligence, to improve the quality of life of long-term breast cancer survivors, and self-efficacy for the management of late sequelae from primary care.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz za sobą diagnozę raka piersi.
- •Zakończyłaś chemioterapię i/lub radioterapię ponad 5 lat temu.
- •Obecnie nie masz nawrotu choroby.
- •Jesteś kobietą powyżej 18 roku życia.
- •Potrafisz korzystać z internetu.
✗ Disqualifies
- •Masz zdiagnozowanego innego rodzaju raka niż rak piersi.
- •Masz nawrót choroby lub przerzuty, które wymagają nowego leczenia.
- •Jesteś mężczyzną.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 99 Years
- Last updated (source)
- September 30, 2025
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Public University of Navarre
Pamplona, Spain
Trial contact
Cristina García-Vivar, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.